CardioDx to Use $60M Funding Round to Make Clinical Utility Case for Corus CAD

CardioDx will use the funding to complete additional studies that demonstrate the clinical utility of Corus CAD, continue to educate primary care physicians and cardiologists as to how the test can be used in the care of their patients, and reach out to payors to help them understand the circumstances under which they should pay for the test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories